Why the study?
Does the timing of natural rotavirus infection relative to WC3 bovine rotavirus vaccination affect serotype-specific neutralizing antibody responses in infants?
Does the timing of natural rotavirus infection relative to WC3 bovine rotavirus vaccination affect serotype-specific neutralizing antibody responses in infants?
Vaccination with WC3 bovine rotavirus can boost neutralizing antibody titers to human serotypes in infants primed by a previous natural rotavirus infection.
May enhance heterotypic neutralizing responses to WC3 after serotype 1 priming; extends priming data but leaves open optimal timing in trials.
In an evaluation of WC3 bovine rotavirus (serotype 6) vaccine in infants, some subjects experienced a natural serotype 1 rotavirus infection before vaccination and others after. Therefore, the effects of both WC3 and natural rotavirus strains as either primary or boosting immunogens on serotype-specific neutralizing antibody responses could be determined. After primary natural infection (symptomatic or asymptomatic), neutralizing antibody titers were highest to serotype 1 but were consistently high to serotype 3, and low titers (greater than or equal to 20) to serotypes 2 and 4 were often detected. Previous vaccination with WC3 had little effect on the magnitude of these responses. In contrast, subjects infected with serotype 1 strains before vaccination experienced large (average, 12-fold) rises in neutralizing antibody to human serotypes 1-4 when vaccinated with WC3. Thus, although WC3 and the natural strains are distinct serotypes, their epitopes were sufficiently similar that reinfection with WC3 could boost neutralizing antibody titers to human serotypes in subjects primed by a previous natural infection.
No takes yet. Share an insight, caveat, or question.
Ward et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: